Interesting Stocks: First United Corporation (NASDAQ:FUNC), Haverty Furniture Companies (NYSE:HVT), Cytori Therapeutics (NASDAQ:CYTX), ORBCOMM (NASDAQ:ORBC)

S&W Seed Company (NASDAQ:SANW) shares fell -0.93% in last trading session and ended the day at $4.25. SANW Gross Margin is 20.20% and its has a return on assets of -1.00%. S&W Seed Company (NASDAQ:SANW) quarterly performance is 1.43%.

On March 18, 2016, S&W Seed Company (NASDAQ:SANW) entered into employment agreements with Mark S. Grewal, Matthew K. Szot and Dennis C. Jury, providing terms negotiated between each of the foregoing executive officers and the Compensation Committee of the Board of the Directors (the “Compensation Committee”).

First United Corporation (NASDAQ:FUNC) ended the last trading day at $11.22. Company weekly volatility is calculated as 2.35% and price to cash ratio as 1.35. First United Corporation (NASDAQ:FUNC) showed a weekly performance of 2.00%.

On 30 March, Haverty Furniture Companies Inc. (NYSE:HVT) shares advanced 0.56% and was closed at $21.41. HVT EPS growth in last 5 year was 27.70%. Haverty Furniture Companies Inc. (NYSE:HVT) year to date (YTD) performance is 0.35%.

Haverty Furniture Companies Inc. (NYSE:HVT) announced that Allison Dukes, president, chairman and CEO of the Atlanta Division of SunTrust Banks, Inc., has been nominated to stand for election to the company’s board of directors at the annual meeting of stockholders in May. The company also announced that Terry McGuirk, has decided not to seek re-election to the board of directors and will retire from the board at the expiration of his current term in May 2016.

Cytori Therapeutics, Inc. (NASDAQ:CYTX) shares fell -0.25% in last trading session and ended the day at $0.20. CYTX Gross Margin is 72.60% and its has a return on assets of -103.20%. Cytori Therapeutics, Inc. (NASDAQ:CYTX) quarterly performance is 1.25%.

Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced that its U.S. FDA approved Phase III STAR trial has enrolled and treated its 40th patient (50% of target enrollment). In addition, a pre-specified independent data monitoring committee review of safety data from the initial 20 patients has been conducted and the committee has recommended that the study continue as planned.

ORBCOMM, Inc. (NASDAQ:ORBC) caters to the Technology space. It has a net profit margin of -7.50% and weekly performance is 9.59%. On the last day of trading company shares ended up at $10.06.

ORBCOMM Inc (NASDAQ:ORBC) had its price objective upped by Northland Securities from $9.00 to $11.00 in a report published on Monday. They currently have an outperform rating on the stock.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *